Lexeo Therapeutics, Inc (LXEO)
Lexeo Therapeutics (LXEO) sees significant social media buzz with a 220% surge in social dominance, driven by discussions around FDA alignment and its potential as a bet on future leadership changes.
About Lexeo Therapeutics, Inc
Lexeo Therapeutics, Inc. is a biotechnology company focused on gene therapy.
Lexeo Therapeutics, Inc uses the ticker $LXEO for trading. Listed in the Stocks category.
Insights
- Lexeo Therapeutics, Inc (LXEO) social dominance hit [------] which is 220% higher than it's daily average.
- Lexeo Therapeutics, Inc (LXEO) social dominance is up 1566.67% from the previous week.
- Lexeo Therapeutics, Inc (LXEO) Galaxy Score™ is up 44.12% from the previous week.
- Lexeo Therapeutics, Inc (LXEO) engagements is up 121.65% from the previous week.
- Lexeo Therapeutics, Inc (LXEO) mentions is up 27.27% from the previous week.
- Lexeo Therapeutics, Inc (LXEO) posts created is up 143.75% from the previous week.
Price: $6.30
Price 24-Hour Time-Series Raw Data
The current price action is heavily influenced by regulatory uncertainty, causing a sharp decline. However, strong community support and educational content are providing a floor, suggesting a potential rebound if clarity emerges.
24-Hour: -3.96% 7-Day: -9.86% 30-Day: -14.61%
1-Year High: $10.60 on 2025-12-22
1-Year Low: $3.10 on 2025-06-04
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Lexeo Therapeutics, Inc (LXEO) is currently AltRank #1,302 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [----]
1-Year High: [-----] on 2026-02-02
1-Year Low: [---] on 2026-01-25
Galaxy Score: [--]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +15
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-01-23
1-Year Low: [--] on 2026-02-13
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] +122%
[--] Month: [------] -90%
[--] Months: [-------] -11%
[--] Year: [---------] +150%
1-Year High: [-------] on 2025-10-07
1-Year Low: [---] on 2025-09-07
Engagements by network (24h): News: [--] X: [-----] YouTube: [--] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +27%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): News: [--] X: [--] YouTube: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Lexeo Therapeutics, Inc (LXEO) in the last [--] hours which is down 57% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +9%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07
The most influential creators that mention Lexeo Therapeutics, Inc in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @STL_Biotech | [--] | [-----] | [--] | [-----] |
| @Ellie18153 | [--] | [--] | [--] | [--] |
| @Stock_Analysis8 | [--] | [--] | [--] | [--] |
| @Angelinafrazier | [--] | [--] | [--] | |
| @David_Tonkinn | [--] | [--] | [--] | [--] |
| @semodough | [--] | [------] | [--] | [--] |
| @Stock_Marketr18 | [--] | [--] | [--] | [--] |
| @Rubi51030 | [--] | [--] | [--] | [--] |
| @Signal_Trader01 | [--] | [--] | [--] | [--] |
| @Crypto_Update31 | [--] | [--] | [--] | [--] |
Sentiment: 44%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 44%
Daily Average: 80%
[--] Week: 25% -58%
[--] Month: 44% -23%
[--] Months: 44% -27%
[--] Year: 44% -56%
1-Year High: 100% on 2025-02-17
1-Year Low: 11% on 2025-09-18
Most Supportive Themes:
- Community Building: (45%) Focus on fostering a strong and engaged community through interactive content and discussions.
- Educational Content: (30%) Providing valuable information and insights to help users learn and grow within the topic.
Most Critical Themes:
- Market Volatility: (1%) Significant fluctuations in market value are causing concern among investors.
- Regulatory Uncertainty: (1%) Unclear or changing regulations are creating a challenging environment for adoption and growth.
Social Dominance: 0.00533%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00533%
Daily Average: 0.00553%
[--] Week: 0.005% +0.0047%
[--] Month: 0.018% +0.012%
[--] Months: 0.018% +0.013%
[--] Year: 0.018% +0.011%
1-Year High: 0.031% on 2025-06-29
1-Year Low: 0.0006% on 2025-09-30
Market Dominance: 0.0005216982485766708%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0005216982485766708%
Daily Average: 0%
1-Year High: 0.00066% on 2026-01-14
1-Year Low: 0.00052% on 2026-02-16
Market Cap: $460,550,033
Market Cap 24-Hour Time-Series Raw Data
Current Value: $460,550,033
Daily Average: $527,197,890
[--] Week: $469,308,513 -11%
[--] Month: $460,550,033 -15%
1-Year High: $563,462,164 on 2026-01-14
1-Year Low: $460,550,033 on 2026-02-13
Top Lexeo Therapeutics, Inc Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"So now that we know FDA alignment is meaningless under new regime is $LXEO pivotal just a bet VP is gone in 2yrs FWIW probably not an un reasonable bet"
X Link @STL_Biotech 2026-02-16T14:49Z [----] followers, [----] engagements
"@PersimmonTI @NatRevDrugDisc Lot of overlap too its becoming hard to keep them all straight. Take $LXEO for example; lead asset has BTD FTD Orphan Drug RPD CDRP RMAT accelerated approval pathway. Everything but a CNPV"
X Link @STL_Biotech 2026-02-16T13:04Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing